Celltrion shares rise after bonus issue announcement   

Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...

US PE firm Miri Capital ups stake in Korea’s STIC Investments

US private equity firm Miri Capital Management LLC said on Tuesday it has raised its stake in STIC Investments Inc. to step up its shareholder activ...

Samsung Bioepis Q1 sales surpass $362 mn in US, Europe

Samsung Bioepis Co. reported that its quarterly overseas sales of key biosimilars exceeded 500 billion won ($362 million), according to figures re...

OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...

Samsung, Bayer join $90 mn investment in AI healthcare app Ada Health

Samsung Electronics Co. and Germany’s pharmaceutical giant Bayer AG have made a joint investment in the Berlin-based artificial intelligence (...